An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Ove… (NCT04212364) | Clinical Trial Compass
CompletedNot Applicable
An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses
United States614 participantsStarted 2019-03-15
Plain-language summary
The purpose of this study is to pilot and implement a peer mentor intervention focused on overdose prevention and care.
The intervention consists of 3 sessions. During the first and second session, each participant will meet individually with a trained staff member. In the 3rd session, the participant will invite a social network member to attend the session, and these 2 participants will meet with a trained staff member.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for Index participants:
* self-reported use of opiates including heroin, fentanyl, or prescription opiates to get high at least 2 times in the last two weeks;
* willing to invite a network member who uses drugs to the study;
* ages 18-years or older;
* living in the Baltimore metropolitan region, and
* not previously enrolled in the study or currently enrolled in another Lighthouse study.
Inclusion Criteria for network participants:
* self-reported use of illicit injecting or non-injecting opiates at least 2 times in the last two weeks;
* sees the Index participant 2 or more times in the past week;
* ages 18 years or older; and
* living in the Baltimore metropolitan region.
Exclusion Criteria:
* Index participants may not take part in the study as a Network participant.
* Network participants may not take part in the study as an Index participant.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Network Enrollment
Timeframe: 6 months
Trial details
NCT IDNCT04212364
SponsorJohns Hopkins Bloomberg School of Public Health